Sunmax Biotechnology Co., Ltd. (4728.TWO)
TWD 276.0
(-0.18%)
TWD 276.0
(-0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.68 Billion | 1.4 Billion | 1.03 Billion | 855.85 Million | 594.14 Million |
| Cost of Revenue | 284.09 Million | 207.27 Million | 141.21 Million | 154.64 Million | 86.81 Million |
| Gross Profit | 1.4 Billion | 1.19 Billion | 894.44 Million | 701.2 Million | 507.33 Million |
| Operating Expenses | 510.09 Million | 425.19 Million | 526.83 Million | 371.26 Million | 331.9 Million |
| Selling, General and Administrative Expenses | 481.35 Million | 407.22 Million | 502.2 Million | 353.73 Million | 309.29 Million |
| Research and Development Expenses | 28.74 Million | 17.97 Million | 24.62 Million | 17.53 Million | 22.6 Million |
| Other Expenses | - | 467 Thousand | -5.74 Million | 11.57 Million | - |
| Cost and Expenses | 794.19 Million | 632.46 Million | 668.04 Million | 525.91 Million | 418.71 Million |
| Operating Income | 894.79 Million | 777.67 Million | 362.63 Million | 346.44 Million | 175.42 Million |
| Interest Expense | 2.94 Million | 1.34 Million | 2.8 Million | 2.91 Million | 2.74 Million |
| Income Tax Expense | 283.68 Million | 243.34 Million | 111.84 Million | 99.68 Million | 53.97 Million |
| Earnings before Tax | 909.39 Million | 777.17 Million | 357.48 Million | 337.75 Million | 154.41 Million |
| Net Income | 625.7 Million | 533.83 Million | 245.64 Million | 238.07 Million | 100.44 Million |
| Earnings Per Share Basic | 11.49 | 9.80 | 4.51 | 4.37 | 1.84 |
| Earnings Per Share Diluted | 11.47 | 9.79 | 4.51 | 4.37 | 1.84 |
| Weighted Average Shares Outstanding | 54.46 Million | 54.46 Million | 54.46 Million | 54.46 Million | 54.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.53 Million | 54.53 Million | 54.52 Million | 54.53 Million | 54.53 Million |
| Gross Margin | 0.83 | 0.85 | 0.86 | 0.82 | 0.85 |
| EBIT Margin | 0.55 | 0.60 | 0.40 | 0.44 | 0.29 |
| Profit Margin | 0.37 | 0.38 | 0.24 | 0.28 | 0.17 |
| EBITDA | 936.46 Million | 836.35 Million | 415.7 Million | 380.24 Million | 170.79 Million |
| Earnings Before Tax Margin | 0.53 | 0.56 | 0.35 | 0.40 | 0.30 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 453.67 Million | 427.62 Million | 404.52 Million | 1.68 Billion | 473.94 Million | 417.43 Million |
| Cost of Revenue | 77.43 Million | 70.76 Million | 72 Million | 284.09 Million | 82.5 Million | 75.46 Million |
| Gross Profit | 376.24 Million | 356.86 Million | 332.51 Million | 1.4 Billion | 391.44 Million | 341.97 Million |
| Operating Expenses | 122.89 Million | 117.17 Million | 145.09 Million | 510.09 Million | 133.42 Million | 122.03 Million |
| Selling, General and Administrative Expenses | 113.71 Million | 108.33 Million | 136.84 Million | - | 124.41 Million | 116.37 Million |
| Research and Development Expenses | 9.17 Million | 8.83 Million | 8.24 Million | - | 9 Million | 5.65 Million |
| Other Expenses | -1.51 Million | 6.44 Million | 58 Thousand | 2.51 Million | 2.58 Million | -327 Thousand |
| Cost and Expenses | 200.32 Million | 187.93 Million | 217.09 Million | 794.19 Million | 215.92 Million | 197.49 Million |
| Operating Income | 261.46 Million | 256.04 Million | 193.57 Million | 912.46 Million | 275.55 Million | 208.09 Million |
| Interest Expense | 1.52 Million | 1.57 Million | 1.52 Million | 2.94 Million | 703 Thousand | 318 Thousand |
| Income Tax Expense | 77.54 Million | 78.09 Million | 23.33 Million | 283.68 Million | 90.42 Million | 63.25 Million |
| Earnings before Tax | 259.93 Million | 254.45 Million | 191.92 Million | 909.39 Million | 274.85 Million | 207.77 Million |
| Net Income | 182.39 Million | 176.36 Million | 168.58 Million | 625.7 Million | 184.43 Million | 144.51 Million |
| Earnings Per Share Basic | 3.35 | 3.24 | 3.10 | - | 3.39 | 2.65 |
| Earnings Per Share Diluted | 3.35 | 3.23 | 3.09 | - | 3.38 | 2.65 |
| Weighted Average Shares Outstanding | 54.44 Million | 54.46 Million | 54.46 Million | 54.46 Million | 54.4 Million | 54.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.44 Million | 54.53 Million | 54.53 Million | 54.53 Million | 54.56 Million | 54.53 Million |
| Gross Margin | 0.83 | 0.83 | 0.82 | 0.83 | 0.83 | 0.82 |
| EBIT Margin | 0.63 | 0.65 | 0.53 | - | 0.62 | 0.54 |
| Profit Margin | 0.40 | 0.41 | 0.42 | 0.37 | 0.39 | 0.35 |
| EBITDA | 286.25 Million | 280.05 Million | 214.4 Million | - | 294.15 Million | 224.44 Million |
| Earnings Before Tax Margin | 0.58 | 0.60 | 0.48 | 0.54 | 0.58 | 0.50 |
3545
NXGT
ADTN
LHSC
4920
VTSCF